AI could predict which heart ablations work best

NCT ID NCT05371405

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This Stanford study is testing whether machine learning can help predict which patients with atrial fibrillation will benefit from a heart ablation procedure. Researchers will collect data from 120 people undergoing ablation and use it to train an algorithm that forecasts success. The goal is to personalize treatment and identify the best targets for ablation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    RECRUITING

    Stanford, California, 94305, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to more personalized and effective ablation procedures for atrial fibrillation patients.

What could go wrong

This is an early-stage observational study focused on developing a prediction tool, not testing a new treatment. The algorithm may not improve outcomes in practice.

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.